The smart disposable medical device market size has grown exponentially in recent years. It will grow from $6.49 billion in 2025 to $7.8 billion in 2026 at a compound annual growth rate (CAGR) of 20.2%. The growth in the historic period can be attributed to hospital-acquired infection concerns, demand for sterilization-free devices, growth in chronic disease monitoring, wearable technology adoption, regulatory safety requirements.
The smart disposable medical device market size is expected to see rapid growth in the next few years. It will grow to $16.1 billion in 2030 at a compound annual growth rate (CAGR) of 19.9%. The growth in the forecast period can be attributed to remote monitoring expansion, smart drug adherence tools, sustainability-driven material innovation, integration with digital health platforms, outpatient care growth. Major trends in the forecast period include single-use connected medical devices, embedded sensor disposable tools, infection control focused devices, real-time data transmitting disposables, smart drug delivery solutions.
The growing emphasis on reducing hospital-acquired infections is expected to drive the expansion of the smart disposable medical device market in the coming years. Hospital-acquired infections are infections that develop in patients during hospital stays or medical treatment, typically occurring 48 hours or more after admission and not present at the time of entry. The increasing focus on reducing these infections stems from the need to enhance patient safety, as prevention lowers the risk of complications and supports faster recovery. Smart disposable medical devices help minimize hospital-acquired infections by ensuring single-use sterility and offering real-time monitoring, which reduces cross-contamination risks and strengthens patient protection. For instance, in March 2025, the Health Security Agency, a United Kingdom-based government organization, reported that hospital-acquired infections affected 7.6 percent of patients in 2023, with pneumonia and lower respiratory tract infections accounting for 29.6 percent of cases, followed by urinary tract infections at 17.5 percent and sepsis or disseminated infections at 10.6 percent. Therefore, the growing focus on reducing hospital-acquired infections is contributing to the expansion of the smart disposable medical device market.
Leading companies in the smart disposable medical device market are prioritizing innovation and digital health integration through developments such as dual-therapy compatibility, designed to enable seamless monitoring and management of multiple drug types using a single connected platform. Dual-therapy compatibility refers to a smart medical device’s ability to support and track two different therapies or medications simultaneously. For example, in January 2023, Biocorp, a France-based medical technology company, received approval from the US Food and Drug Administration for Mallya, a smart medical device for disposable injector pens. This device allows users of both insulin and GLP-1 receptor agonist pens to connect their devices to a smartphone to track dosage details along with the date and time of each injection. This connectivity feature enhances therapy accuracy, promotes treatment adherence, and improves overall patient outcomes.
In June 2023, Novo Nordisk, a Denmark-based healthcare company, acquired Biocorp for $178 million (154 million euros). This acquisition aims to strengthen Novo Nordisk’s digital health capabilities by integrating Biocorp’s smart connected technologies, such as the Mallya insulin pen sensor, to enhance chronic disease management and improve patient outcomes. Biocorp is a France-based manufacturer specializing in smart disposable medical devices.
Major companies operating in the smart disposable medical device market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, Dexcom Inc., Insulet Corporation, iRhythm Technologies Inc., Ypsomed Holding AG, Biotricity Inc., Tasso Inc., Gentag Inc., Nemaura Medical Inc., Proteus Digital Health Inc., SmartTab Systems Inc., Celero Systems Inc., BlueSpark Technologies Inc., Bodytrak Inc., Element Science Inc., Becton Dickinson and Company, Roche Diagnostics, VitalConnect Inc.
North America was the largest region in the smart disposable medical device market in 2025. The regions covered in the smart disposable medical device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the smart disposable medical device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have increased costs of microchips, sensors, and connectivity modules used in smart disposable medical devices, particularly impacting smart syringes, inhalers, and wearable patches. Asia-Pacific manufacturing hubs supplying North America and Europe are most affected. While tariffs have raised unit costs, they have also accelerated local manufacturing, recyclable material development, and innovation in low-cost smart disposables.
The smart disposable medical device market research report is one of a series of new reports that provides smart disposable medical device market statistics, including smart disposable medical device industry global market size, regional shares, competitors with a smart disposable medical device market share, detailed smart disposable medical device market segments, market trends and opportunities, and any further data you may need to thrive in the smart disposable medical device industry. This smart disposable medical device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A smart disposable medical device is a single-use medical instrument integrated with advanced technologies such as sensors, microprocessors, or wireless communication systems that allow it to collect, monitor, analyze, or transmit physiological or diagnostic data during use. These devices are engineered to maintain high accuracy and reliability throughout their functional lifespan, ensuring precise performance before being safely disposed of to prevent contamination and eliminate the need for sterilization.
The primary product types of smart disposable medical devices include smart syringes, smart inhalers, smart wearable patches, and smart pills. Smart syringes are medical instruments developed to administer injections safely, accurately, and efficiently while minimizing the risks of reuse and incorrect dosing. These devices support various connectivity options such as Bluetooth, near field communication, and wireless fidelity and are utilized for patient monitoring, drug delivery, and diagnostic purposes. They are used across several end-user settings, including hospitals and clinics, home care, and ambulatory surgical centers.
The smart disposable medical device market consists of sales of smart catheters, smart bandages, smart biopsy needles, connected surgical staplers, and smart wound dressings. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The smart disposable medical device market size is expected to see rapid growth in the next few years. It will grow to $16.1 billion in 2030 at a compound annual growth rate (CAGR) of 19.9%. The growth in the forecast period can be attributed to remote monitoring expansion, smart drug adherence tools, sustainability-driven material innovation, integration with digital health platforms, outpatient care growth. Major trends in the forecast period include single-use connected medical devices, embedded sensor disposable tools, infection control focused devices, real-time data transmitting disposables, smart drug delivery solutions.
The growing emphasis on reducing hospital-acquired infections is expected to drive the expansion of the smart disposable medical device market in the coming years. Hospital-acquired infections are infections that develop in patients during hospital stays or medical treatment, typically occurring 48 hours or more after admission and not present at the time of entry. The increasing focus on reducing these infections stems from the need to enhance patient safety, as prevention lowers the risk of complications and supports faster recovery. Smart disposable medical devices help minimize hospital-acquired infections by ensuring single-use sterility and offering real-time monitoring, which reduces cross-contamination risks and strengthens patient protection. For instance, in March 2025, the Health Security Agency, a United Kingdom-based government organization, reported that hospital-acquired infections affected 7.6 percent of patients in 2023, with pneumonia and lower respiratory tract infections accounting for 29.6 percent of cases, followed by urinary tract infections at 17.5 percent and sepsis or disseminated infections at 10.6 percent. Therefore, the growing focus on reducing hospital-acquired infections is contributing to the expansion of the smart disposable medical device market.
Leading companies in the smart disposable medical device market are prioritizing innovation and digital health integration through developments such as dual-therapy compatibility, designed to enable seamless monitoring and management of multiple drug types using a single connected platform. Dual-therapy compatibility refers to a smart medical device’s ability to support and track two different therapies or medications simultaneously. For example, in January 2023, Biocorp, a France-based medical technology company, received approval from the US Food and Drug Administration for Mallya, a smart medical device for disposable injector pens. This device allows users of both insulin and GLP-1 receptor agonist pens to connect their devices to a smartphone to track dosage details along with the date and time of each injection. This connectivity feature enhances therapy accuracy, promotes treatment adherence, and improves overall patient outcomes.
In June 2023, Novo Nordisk, a Denmark-based healthcare company, acquired Biocorp for $178 million (154 million euros). This acquisition aims to strengthen Novo Nordisk’s digital health capabilities by integrating Biocorp’s smart connected technologies, such as the Mallya insulin pen sensor, to enhance chronic disease management and improve patient outcomes. Biocorp is a France-based manufacturer specializing in smart disposable medical devices.
Major companies operating in the smart disposable medical device market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, Dexcom Inc., Insulet Corporation, iRhythm Technologies Inc., Ypsomed Holding AG, Biotricity Inc., Tasso Inc., Gentag Inc., Nemaura Medical Inc., Proteus Digital Health Inc., SmartTab Systems Inc., Celero Systems Inc., BlueSpark Technologies Inc., Bodytrak Inc., Element Science Inc., Becton Dickinson and Company, Roche Diagnostics, VitalConnect Inc.
North America was the largest region in the smart disposable medical device market in 2025. The regions covered in the smart disposable medical device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the smart disposable medical device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have increased costs of microchips, sensors, and connectivity modules used in smart disposable medical devices, particularly impacting smart syringes, inhalers, and wearable patches. Asia-Pacific manufacturing hubs supplying North America and Europe are most affected. While tariffs have raised unit costs, they have also accelerated local manufacturing, recyclable material development, and innovation in low-cost smart disposables.
The smart disposable medical device market research report is one of a series of new reports that provides smart disposable medical device market statistics, including smart disposable medical device industry global market size, regional shares, competitors with a smart disposable medical device market share, detailed smart disposable medical device market segments, market trends and opportunities, and any further data you may need to thrive in the smart disposable medical device industry. This smart disposable medical device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A smart disposable medical device is a single-use medical instrument integrated with advanced technologies such as sensors, microprocessors, or wireless communication systems that allow it to collect, monitor, analyze, or transmit physiological or diagnostic data during use. These devices are engineered to maintain high accuracy and reliability throughout their functional lifespan, ensuring precise performance before being safely disposed of to prevent contamination and eliminate the need for sterilization.
The primary product types of smart disposable medical devices include smart syringes, smart inhalers, smart wearable patches, and smart pills. Smart syringes are medical instruments developed to administer injections safely, accurately, and efficiently while minimizing the risks of reuse and incorrect dosing. These devices support various connectivity options such as Bluetooth, near field communication, and wireless fidelity and are utilized for patient monitoring, drug delivery, and diagnostic purposes. They are used across several end-user settings, including hospitals and clinics, home care, and ambulatory surgical centers.
The smart disposable medical device market consists of sales of smart catheters, smart bandages, smart biopsy needles, connected surgical staplers, and smart wound dressings. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Smart Disposable Medical Device Market Characteristics
3. Smart Disposable Medical Device Market Supply Chain Analysis
4. Global Smart Disposable Medical Device Market Trends and Strategies
5. Smart Disposable Medical Device Market Analysis of End Use Industries
7. Global Smart Disposable Medical Device Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Smart Disposable Medical Device Total Addressable Market (TAM) Analysis for the Market
9. Smart Disposable Medical Device Market Segmentation
10. Smart Disposable Medical Device Market Regional and Country Analysis
11. Asia-Pacific Smart Disposable Medical Device Market
12. China Smart Disposable Medical Device Market
13. India Smart Disposable Medical Device Market
14. Japan Smart Disposable Medical Device Market
15. Australia Smart Disposable Medical Device Market
16. Indonesia Smart Disposable Medical Device Market
17. South Korea Smart Disposable Medical Device Market
18. Taiwan Smart Disposable Medical Device Market
19. South East Asia Smart Disposable Medical Device Market
20. Western Europe Smart Disposable Medical Device Market
21. UK Smart Disposable Medical Device Market
22. Germany Smart Disposable Medical Device Market
23. France Smart Disposable Medical Device Market
24. Italy Smart Disposable Medical Device Market
25. Spain Smart Disposable Medical Device Market
26. Eastern Europe Smart Disposable Medical Device Market
27. Russia Smart Disposable Medical Device Market
28. North America Smart Disposable Medical Device Market
29. USA Smart Disposable Medical Device Market
30. Canada Smart Disposable Medical Device Market
31. South America Smart Disposable Medical Device Market
32. Brazil Smart Disposable Medical Device Market
33. Middle East Smart Disposable Medical Device Market
34. Africa Smart Disposable Medical Device Market
36. Smart Disposable Medical Device Market Competitive Landscape and Company Profiles
37. Smart Disposable Medical Device Market Other Major and Innovative Companies
40. Smart Disposable Medical Device Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Smart Disposable Medical Device Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses smart disposable medical device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for smart disposable medical device? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The smart disposable medical device market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Smart Syringes; Smart Wearable Patches; Smart Pills2) By Connectivity: Bluetooth; Near Field Communication (NFC)
3) By Application: Patient Monitoring; Drug Delivery; Diagnostics
4) By End-User: Hospitals And Clinics; Home Care; Ambulatory Surgical Centers
Subsegments:
1) By Smart Syringes: Connected Insulin Syringes; Connected Vaccination Syringes; Connected Needle-Free Syringes; Connected Prefilled Syringes2) By Smart Wearable Patches: Connected Monitoring Patches; Connected Drug Delivery Patches; Connected Pain Management Patches; Connected Cardiac Monitoring Patches
3) By Smart Pills: Ingestible Monitoring Pills; Ingestible Drug Delivery Pills; Ingestible Temperature Sensing Pills; Ingestible Diagnostic Pills
Companies Mentioned: Abbott Laboratories; Medtronic plc; Boston Scientific Corporation; Terumo Corporation; Dexcom Inc.; Insulet Corporation; iRhythm Technologies Inc.; Ypsomed Holding AG; Biotricity Inc.; Tasso Inc.; Gentag Inc.; Nemaura Medical Inc.; Proteus Digital Health Inc.; SmartTab Systems Inc.; Celero Systems Inc.; BlueSpark Technologies Inc.; Bodytrak Inc.; Element Science Inc.; Becton Dickinson and Company; Roche Diagnostics; VitalConnect Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Smart Disposable Medical Device market report include:- Abbott Laboratories
- Medtronic plc
- Boston Scientific Corporation
- Terumo Corporation
- Dexcom Inc.
- Insulet Corporation
- iRhythm Technologies Inc.
- Ypsomed Holding AG
- Biotricity Inc.
- Tasso Inc.
- Gentag Inc.
- Nemaura Medical Inc.
- Proteus Digital Health Inc.
- SmartTab Systems Inc.
- Celero Systems Inc.
- BlueSpark Technologies Inc.
- Bodytrak Inc.
- Element Science Inc.
- Becton Dickinson and Company
- Roche Diagnostics
- VitalConnect Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 7.8 Billion |
| Forecasted Market Value ( USD | $ 16.1 Billion |
| Compound Annual Growth Rate | 19.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
